Stable Isotopes Product Detail

GSK 525762A-d5

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-T-103436 Stable Isotopes Research Use Only
GSK 525762A-d5
Category
Stable Isotopes
API Family
GSK 525762A
Product Code
CS-T-103436
Research Status
For Laboratory Use

GSK 525762A-d5

GSK 525762A Stable Isotopes
Stock Status: : Enquire Live

CAT No.
CS-T-103436
CAS No.
1260907-17-2(unlabelled)
Molecular Formula
C₂₂H₁₇D₅ClN₅O₂
Molecular Weight
428.93
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
1260907-17-2(unlabelled)
Product Code
CS-T-103436
M.F.
C₂₂H₁₇D₅ClN₅O₂
M.W.
428.93
Smiles
O=C(C[C@H]1C2=NN=C(C)N2C3=C(C(C4=CC=C(Cl)C=C4)=N1)C=C(OC)C=C3)NC([2H])([2H])C([2H])([2H])[2H]
Category
Stable Isotopes
API Family
GSK 525762A
Storage Condition
Refer MSDS for complete information.
IUPAC Name
(4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide-d5; I-BET 762-d5;
References
Zhao, Y., et al.: J. Med. Chem., 56, 7498 (2013); Mirguet, O., et al.: J. Med. Chem., 56, 7501 (2013);
Synonyms
(4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide-d5; I-BET 762-d5;
Application Notes
GSK 525762A-d5, is the labeled analogue of GSK 525762A (G797505), which is a BET Bromodomain Inhibitor currently in clinical development. BET bromodomains have emerged as promising drug targets for treatment of cancers, inflammatory diseases, and other medical conditions.
Hazard Compound
Refer MSDS for complete information.
Overview
GSK 525762A-d5, is the labeled analogue of GSK 525762A (G797505), which is a BET Bromodomain Inhibitor currently in clinical development. BET bromodomains have emerged as promising drug targets for treatment of cancers, inflammatory diseases, and other medical conditions.

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.